Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Eli Lilly and Company
Rondo Therapeutics
BeOne Medicines
ViroMissile, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
MacroGenics
OncoNano Medicine, Inc.
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Toray Industries, Inc
Totus Medicines
Incyte Corporation
Monopar Therapeutics
Monopar Therapeutics
Black Diamond Therapeutics, Inc.
Revolution Medicines, Inc.
Seagen Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Brown University
Xencor, Inc.
ADC Therapeutics S.A.
Arcus Biosciences, Inc.
Pfizer
STCube, Inc.
Zhejiang University
Celon Pharma SA
Adaptimmune
Corvus Pharmaceuticals, Inc.
QuantumLeap Healthcare Collaborative
Emory University
Canadian Cancer Trials Group
Quadriga Biosciences, Inc.
Revolution Medicines, Inc.
Imperial College London
Augusta University
Pfizer
MacroGenics
MacroGenics
EMD Serono